Open Access

ANGPTL3 antisense oligonucleotide to lower triglycerides

Congress Session

About the speaker

Doctor Daniel Gaudet

University of Montreal, Montreal (Canada)
1 presentation
0 follower

2 more presentations in this session

Apolipoprotein C-III Reduction in Cardiovascular Disease

Speaker: Doctor J. Tardif (Montreal, CA)


Final Results of the EVAPORATE Trial

Speaker: Doctor M. Budoff (Torrance, US)


Access the full session

Late-Breaking Science in Lipids

Speakers: Doctor D. Gaudet, Doctor J. Tardif, Doctor M. Budoff

About the event


ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

SGLT-2 inhibitors in patients with and without a history of heart failure: a meta-analysis

27 August 2021

Open Access

Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis

27 August 2021

Open Access

Distribution of cardiovascular risk in type 2 diabetes: results of an analysis using data from the CAPTURE study

27 August 2021

This platform is supported by

logo Novo Nordisk